Skip to main content

Table 1 Demographic and clinical data for each group

From: The impact of intravenously administered dexketoprofen trometamol on analgesia and recovery in ambulatory dilatation and curettage procedures: a retrospective analysis

 

Grup T

(n=60)

Grup P

(n=60)

Grup D

(n=60)

p-value

Age (year)

35.50±8.8

36.68±10.5

32.30±8.7a

0.033

Height (cm)

160.32±5.7

160.28±5.0

160.18±6.1

0.991

Weight (kg)

70.10±12.3

69.15±13.9

69.15±13.8

0.905

BMI

27.22±4.1

26.85±4.9

27.00±5.4

0.916

ASA (I/II) (n)

53/7

49/11

47/13

0.336

R/C (%)

76.7

66.7

91.7

0.007£

Duration of anesthesia (min)

6.35±3.0

7.07±3.7

6.93±3.5

0.484

Duration of operation (min)

5.83±3.0

6.05±3.7

6.32±3.0

0.725

First dose of propofol (mg/kg)

1.51±0.52

1.52±0.39

1.51±0.47

0.905

Additional dose of propofol (mg/kg)

0.66±0.57

0.74±0.60

0.68±0.52

0.744

Total dose of propofol (mg/kg)

2.18±0.56

2.26±0.61

2.19±0.53

0.678

  1. Values are expressed as mean ± standard deviation or n. a Groups with dexketoprofen trometamol and paracetamol were found to have significant differences. £ Since the significance value was 0.007, the relationship between the patient diagnosis and the groups was statistically significant
  2. ASA American Society of Anesthesiologists, T tramadol, P paracetamol, D dexketoprofen trometamol, R/C revision curettage (pregnancy termination)